Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,737 | -25,329 | -17,602 | -11,171 | -5,234 |
| Accounts payable and accrued liabilities | 192 | 3,273 | 1,158 | 214 | 241 |
| Other Working Capital | -3,432 | -1,137 | -3,796 | -3,885 | -1,223 |
| Other Operating Activity | 1,351 | 5,879 | 6,537 | 5,125 | 3,194 |
| Operating Cash Flow | $-11,626 | $-17,313 | $-13,704 | $-9,716 | $-3,022 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 5 | 5 | N/A | N/A |
| Other Financing Activity | 7 | 0 | 0 | 5 | 5 |
| Financing Cash Flow | $7 | $5 | $5 | $5 | $5 |
| Beginning Cash Position | 28,378 | 45,686 | 45,686 | 45,686 | 45,686 |
| End Cash Position | 16,759 | 28,378 | 31,987 | 35,974 | 42,669 |
| Net Cash Flow | $-11,619 | $-17,308 | $-13,699 | $-9,712 | $-3,017 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,626 | -17,313 | -13,704 | -9,716 | -3,022 |
| Free Cash Flow | -11,626 | -17,313 | -13,704 | -9,716 | -3,022 |